Metabolic Fatty Liver Disease: Serum Ferritin as a Prognostic Marker

被引：0
|
作者：
Simon, Annika
机构：
来源：
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2024年 / 62卷 / 08期
关键词：
D O I：
10.1055/a-2307-9710
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Although hyperferritinemia in patients with metabolic fatty liver disease - also known by the abbreviation MASLD - can show associations with the severity of liver fibrosis, the data on the prognostic benefit of ferritin determination remains unclear to date. Armandi et al. therefore wanted to close a gap and conducted a multicenter cohort study on the topic.
引用
收藏
页码：1175 / 1176
页数：2
相关论文
共 50 条
  • [41] Serum Ferritin Levels Do not Predict the Stage of Underlying Non-Alcoholic Fatty Liver Disease
    Chandok, Natasha
    Minuk, Gerald
    Wengiel, Matias
    Uhanova, Julia
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2012, 21 (01) : 53 - 58
  • [42] Association between serum ferritin and uric acid levels and nonalcoholic fatty liver disease in the Chinese population
    Zhou, Fangli
    He, Xiaoli
    Liu, Dan
    Ye, Yan
    Tian, Haoming
    Tian, Li
    PEERJ, 2023, 11
  • [43] Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease
    Kowdley, Kris V.
    Belt, Patricia
    Wilson, Laura A.
    Yeh, Matthew M.
    Neuschwander-Tetri, Brent A.
    Chalasani, Naga
    Sanyal, Arun J.
    Nelson, James E.
    HEPATOLOGY, 2012, 55 (01) : 77 - 85
  • [44] Clinical and prognostic value of metabolic disorders in non-alcoholic fatty liver disease
    Vakhrushev, Ya. M.
    Suchkova, E. V.
    Lukashevich, A. P.
    TERAPEVTICHESKII ARKHIV, 2020, 92 (12) : 31 - 35
  • [45] Nonalcoholic Fatty Liver Disease Without Metabolic-associated Fatty Liver Disease and the Risk of Metabolic Syndrome
    Sinn, Dong Hyun
    Kang, Danbee
    Choi, Sung Chul
    Hong, Yun Soo
    Zhao, Di
    Guallar, Eliseo
    Park, Yewan
    Cho, Juhee
    Gwak, Geum-Youn
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (07) : 1873 - +
  • [46] ELEVATED SERUM FERRITIN IS ASSOCIATED WITH CIRRHOSIS-PROMOTING GENETIC VARIANTS BUT NOT WITH HFE MUTATIONS IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE
    Suresh, Deepika
    Krach, Kristin
    Chen, Vincent L.
    GASTROENTEROLOGY, 2023, 164 (06) : S1293 - S1294
  • [47] Metabolic associated fatty liver disease (MAFLD): a milestone in the history of fatty liver disease
    Alharthi, Jawaher
    Eslam, Mohammed
    HEPATOBILIARY SURGERY AND NUTRITION, 2021, 10 (05) : 696 - 698
  • [48] Serum thioredoxin elucidates the significance of serum ferritin as a marker of oxidative stress in chronic liver diseases
    Sumida, Y
    Nakashima, T
    Yoh, T
    Kakisaka, Y
    Nakajima, Y
    Ishikawa, H
    Mitsuyoshi, H
    Okanoue, T
    Nakamura, H
    Yodoi, J
    LIVER, 2001, 21 (05): : 295 - 299
  • [49] EVALUATION OF SERUM FERRITIN AS A MARKER FOR ADULT STILL DISEASE-ACTIVITY
    SCHWARZEYWILL, M
    HEILIG, B
    BAUER, H
    BREITBART, A
    PEZZUTTO, A
    ANNALS OF THE RHEUMATIC DISEASES, 1992, 51 (05) : 683 - 685
  • [50] Clinical usage of serum ferritin to assess liver fibrosis in patients with non-alcoholic fatty liver disease: Proceed with caution
    Yoneda, Masato
    Thomas, Emmanuel
    Sumida, Yoshio
    Imajo, Kento
    Eguchi, Yuichiro
    Hyogo, Hideyuki
    Fujii, Hideki
    Ono, Masafumi
    Kawaguchi, Takumi
    Schiff, Eugene R.
    HEPATOLOGY RESEARCH, 2014, 44 (14) : E499 - E502
12345